Valeska Schroeder

We are transforming ophthalmology and optometry by addressing the underlying causes of two of the world’s most prevalent eye diseases, glaucoma and dry eye.

Intuity Medical, Inc. was founded to make blood glucose testing simple, easy, and discreet for millions of people who have diabetes. Our POGO Automatic® Blood Glucose Monitoring System is the world’s first FDA-cleared One-Step™ blood glucose meter that does all the work automatically for patients. It combines lancing, blood collection, and analysis into a single 10-test cartridge. This revolutionary technology offers a convenient, discreet solution for patients who need to regularly test their blood glucose. Patterns®, our secure HIPAA-compliant app, syncs patients’ POGO Automatic data so they can easily track blood glucose results on their iOS- or Android-based phone or their computer via USB cable. This gives patients and healthcare professionals a comprehensive way to detect and manage important patterns and trends that affect overall blood glucose control.

Aerin’s mission is to provide Ear, Nose, and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal airway conditions. The company’s FDA-cleared products, VivAer® for nasal airway obstruction and RhinAer® for chronic rhinitis, leverage Aerin’s proprietary, temperature-controlled technology, which allows ENT physicians to reliably improve patients’ symptoms with an in-office procedure performed with local anesthetic. For more information, please visit www.aerinmedical.com. Full Social Media Terms of Use are available at aerinmedical.com/social-terms-of-use

BioInspire is a Palo Alto-based medical technology start-up with a groundbreaking new product to manage chronic sinusitis.

Lungpacer Medical, Inc., is a privately held medical device company focused on improving respiratory and critical care medicine. Headquartered in Vancouver, Canada, and with US offices in Exton, Pennsylvania, Lungpacer Medical is dedicated to designing non-surgical, minimally invasive technologies to ventilate patients more safely and effectively. The Lungpacer Diaphragm Pacing Therapy System™ is the first, minimally invasive, temporary transvenous diaphragmatic neurostimulation system that has FDA Emergency Use Authorization (EUA) for use during the COVID-19 pandemic. This non-surgical, non-implanted, diaphragm stimulation therapy is delivered via a central venous catheter (Lungpacer IntraVenous Electrode - LIVE Catheter®), similar to catheters currently placed in mechanically ventilated ICU patients. The LIVE Catheter is intended to stimulate the diaphragm in conjunction with an invasive mechanical ventilator. This device is designed to strengthen a weakened diaphragm already atrophied by mechanical ventilation (also known as VIDD) which may help patients wean off the ventilator more rapidly. The Lungpacer DPTS has neither been cleared or approved for the indication to assist in weaning patients off ventilators in healthcare settings during the COVID-19 pandemic. The Lungpacer DPTS has been authorized for the above emergency use by FDA under an EUA. The Lungpacer DPTS has been authorized only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of medical devices under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. For more information on Emergency Use Authorization visit https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations-medical-devices.

We are transforming ophthalmology and optometry by addressing the underlying causes of two of the world’s most prevalent eye diseases, glaucoma and dry eye.

Intuity Medical, Inc. was founded to make blood glucose testing simple, easy, and discreet for millions of people who have diabetes. Our POGO Automatic® Blood Glucose Monitoring System is the world’s first FDA-cleared One-Step™ blood glucose meter that does all the work automatically for patients. It combines lancing, blood collection, and analysis into a single 10-test cartridge. This revolutionary technology offers a convenient, discreet solution for patients who need to regularly test their blood glucose. Patterns®, our secure HIPAA-compliant app, syncs patients’ POGO Automatic data so they can easily track blood glucose results on their iOS- or Android-based phone or their computer via USB cable. This gives patients and healthcare professionals a comprehensive way to detect and manage important patterns and trends that affect overall blood glucose control.

Cerapedics is a global, commercial-stage ortho-biologics company that aspires to transform the standard of care for bone repair by healing bones faster and at higher rates, without compromising safety, so that patients can live their healthiest lives. Bone grafts, including Cerapedics’ products, are used in over four million annual spine, orthopedics, trauma and interventional procedures world-wide. Cerapedics’ product, i-FACTOR®, is FDA approved for single level cervical spinal fusions in the United States. Cerapedics’ next-generation product is currently being evaluated for use in lumbar interbody fusion through ASPIRE, a pivotal IDE study, and has been granted a Breakthrough Device Designation by the FDA. Cerapedics is headquartered in Westminster, CO.

Aerin’s mission is to provide Ear, Nose, and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal airway conditions. The company’s FDA-cleared products, VivAer® for nasal airway obstruction and RhinAer® for chronic rhinitis, leverage Aerin’s proprietary, temperature-controlled technology, which allows ENT physicians to reliably improve patients’ symptoms with an in-office procedure performed with local anesthetic. For more information, please visit www.aerinmedical.com. Full Social Media Terms of Use are available at aerinmedical.com/social-terms-of-use